Dadswell Charles

Avg. Two Year Performance

No purchase track record
(22%) Avg. Sale Return
(11%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)3%(5%)(8%)(22%)
Sale Success Rate15 of 6815 of 6810 of 6811 of 6813 of 68
Drugs » Biotechnology

SVP, General Counsel:

Holdings: 22.3K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--